Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma

BACKGROUND: Recently, S-1, a novel 5-fluorouracil (5-FU)-based agent containing the strong dihydropyrimidine dehydrogenase (DPD) inhibitor, 5-chloro-2,4-dihydropyrimidine (CDHP) has been clinically used to treat various non-urothelial carcinomas (UC). High levels of thymidylate synthase (TS), the ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Hiroki, Kikuchi, Eiji, Hasegawa, Masanori, Kozakai, Norihide, Kosaka, Takeo, Miyajima, Akira, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522564/
https://www.ncbi.nlm.nih.gov/pubmed/22998564
http://dx.doi.org/10.1186/1471-2407-12-420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522564/
https://www.ncbi.nlm.nih.gov/pubmed/22998564
http://dx.doi.org/10.1186/1471-2407-12-420

Ejemplares similares